Skip to content
10-Q

Quarterly Report

Odyssey Health, Inc. ODYY

0001683168-25-009080

← back to feed
Filed
Dec 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Dec 11, 2025 99.85M sh
Shares Diluted Q1 2026 · Oct 31, 2025 106.04M sh
Shares Diluted Q1 2026 · Oct 31, 2024 104.71M sh
Operating Cash Flow Q1 2026 · Oct 31, 2025 −$284K
Operating Cash Flow Q1 2026 · Oct 31, 2024 −$248.51K
Stockholders Equity Q1 2026 · Oct 31, 2025 −$7.16M
Stockholders Equity Q1 2026 · Jul 31, 2025 −$6.95M
Stockholders Equity Q1 2026 · Oct 31, 2024 −$6.28M
Stockholders Equity Q1 2026 · Jul 31, 2024 −$5.33M
Current Liabilities Q1 2026 · Oct 31, 2025 $7.3M
Current Liabilities Q1 2026 · Jul 31, 2025 $7M
Current Assets Q1 2026 · Oct 31, 2025 $143.62K
Current Assets Q1 2026 · Jul 31, 2025 $49.72K
Total Assets Q1 2026 · Oct 31, 2025 $143.62K
Total Assets Q1 2026 · Jul 31, 2025 $49.72K
Eps Diluted Q1 2026 · Oct 31, 2025 $0.00
Eps Diluted Q1 2026 · Oct 31, 2024 −$0.01
Eps Basic Q1 2026 · Oct 31, 2025 $0.00
Eps Basic Q1 2026 · Oct 31, 2024 −$0.01
Sga Expense Q1 2026 · Oct 31, 2025 $303.19K
Sga Expense restated Q1 2026 · Oct 31, 2024 $579.43K
Net Income Q1 2026 · Oct 31, 2025 −$483.45K
Net Income Q1 2026 · Oct 31, 2024 −$1.02M
Operating Income Q1 2026 · Oct 31, 2025 −$303.19K
Operating Income restated Q1 2026 · Oct 31, 2024 −$579.43K